Tilmicosin/γ-Cyclodextrin complexation through supercritical carbon dioxide assistance and its pharmacokinetic and antibacterial study
Document Type
Article
Publication Date
12-1-2022
Abstract
Tilmicosin, as an effective broad-spectrum antibacterial drug, has incomplete absorption and low bioavailability due to its low water solubility, which limits its veterinary clinical applications. As a non-polymeric drug carrier, γ-cyclodextrin was complexed with tilmicosin through supercritical carbon dioxide assistance for the first time, and confirmed by FTIR, X-ray diffraction, proton NMR and scanning electron microscopy. The water solubility of tilmicosin was increased 57-fold through complexation with γ-cyclodextrin, and the release and bioavailability of tilmicosin in the complex were significantly improved. The tilmicosin in complex showed better anti-Streptococcus agalactiae activity than that of tilmicosin alone in MIC, MBC and drug susceptibility studies.
Publication Title
European Journal of Pharmaceutics and Biopharmaceutics
First Page Number
104
Last Page Number
112
DOI
10.1016/j.ejpb.2022.10.024
Recommended Citation
Ding, Yili; Yu, Bo; Zhang, Jianzhou; Ding, Charles; Zhang, Zhiyuan; Xu, Shufeng; Li, Lu; and Yu, Hui, "Tilmicosin/γ-Cyclodextrin complexation through supercritical carbon dioxide assistance and its pharmacokinetic and antibacterial study" (2022). Kean Publications. 491.
https://digitalcommons.kean.edu/keanpublications/491